Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN132,86133,080,45
Msft-1,84
Nokia6,9586,976-2,80
IBM-3,43
Mercedes-Benz Group AG50,8650,86-1,51
PFE-1,61
21.03.2026 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 20.03.2026 18:00:00
Volvo AB (VOLVa.ST, Stockholm)
Poslední obchod Změna (%) Změna (SEK) Objem obchodů (SEK)
287,00 -2,51 -7,40 112 263 899
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 23.03.2026
Popis společnosti

Business Summary: Volvo AB is Sweden- based company primarily engaged in providing transport and infrastructure solutions. The Company scope of activity includes manufacturing of trucks, buses, construction equipment as well as marine and industrial engines.In addition to vehicles and machines, Company offering includes various types of services such as financing, insurance, rentals, spare parts, repairs, preventive maintenance, service agreements and assistance services. The majority of the Volvo AB customers are companies within the transportation or infrastructure industries. The Volvo Group sells its products under the Volvo, Volvo Penta, Rokbak, Renault Trucks, Prevost, Nova Bus, Mack and Arquus brands.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Volvo AB revenues decreased 9% to SEK479.18B. Net income applicable to common stockholders decreased 32% to SEK34.46B. Revenues reflect Trucks segment decrease of 10% to SEK319.7B, Construction Equipment segment decrease of 8% to SEK80.95B, Group & Other and Eliminations segment decrease of 35% to SEK9.55B, United States segment decrease of 15% to SEK114.3B, Europe segment decrease of 14% to SEK114.95B.



  • Poslední aktualizace: 23.03.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorPascal Soriot6601.10.201201.10.2012
Chief Financial Officer, Executive DirectorAradhana Sarin-01.08.202101.08.2021
Chief Human Resources Officer, Chief Compliance Officer, General CounselJeffrey Pott-01.01.2009
Executive Vice President - Bio Pharmaceuticals Research and DevelopmentSharon Barr-
Executive Vice President - Global Operations, Information Technology and Chief Sustainability OfficerPam Cheng-
Executive Vice President - Bio Pharmaceuticals Business UnitRuud Dobber61
Executive Vice President - Oncology Haematology Business UnitDavid Fredrickson50
Executive Vice President - Oncology Haematology Research and DevelopmentSusan Galbraith-
Executive Vice President, InternationalIskra Reic-04.12.2024
Chief Strategy Officer, Chief Executive Officer - AlexionMarc Dunoyer7201.08.202101.01.2013